Amgen Completes $300 M Expansion at Ireland Site
Amgen has opened a new $300 million facility in Dun Laoghaire, County Dublin, Ireland. The development of the new facility included the construction of an 11,500 square meter production plant known as Production Module 3, a new 5,800 square metre cold-chain warehouse and major refurbishment of the other buildings that already existed on site. Additionally, the new syringe filling facility adds to the capabilities that already exist at the site and positions the Dublin plant as a key location within Amgen's global organization.
Amgen Dun Laoghaire (ADL) is an aseptic operations facility, specializing in secondary manufacturing activities: formulation, fill, lyophilization and packaging. The ADL site also includes laboratories and cold-chain warehouse capabilities. The $300 million expansion of the facility completed in 2015 further strengthens the capabilities of the site and offers further capabilities to the Amgen network. Work on the project, which was supported by the Department of Jobs through IDA Ireland, began in November 2011.
Source: IDA Ireland